Effect of dose timing in relation to food intake on systemic exposure to blonanserin
- 20 May 2010
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 66 (9) , 899-902
Abstract
Blonanserin is a novel potent dopamine D2 and serotonin 5-HT2 antagonist for treating schizophrenia. The aim of this study was to investigate prandial effects on systemic exposure to blonanserin in healthy volunteers, with particular attention paid to the effect of dose timing relative to meal intake.Keywords
This publication has 11 references indexed in Scilit:
- Efficacy of blonanserin in combination therapy for treatment‐resistant depressionPsychiatry and Clinical Neurosciences, 2009
- Influence of food intake on the bioavailability and efficacy of oral calcitoninBritish Journal of Clinical Pharmacology, 2009
- Effect of food on systemic exposure to niflumic acid following postprandial administration of talniflumateEuropean Journal of Clinical Pharmacology, 2008
- Effect of timing of dosing in relation to food intake on the pharmacokinetics of esomeprazoleBritish Journal of Clinical Pharmacology, 2007
- Monitoring adverse drug reactions: scales, profiles, and checklistsInternational Nursing Review, 2004
- Time effects of food intake on the pharmacokinetics and pharmacodynamics of quazepam2003
- Effect of Dietary Fat Content in Meals on Pharmacokinetics of QuazepamThe Journal of Clinical Pharmacology, 2002
- Drug, Meal and Formulation Interactions Influencing Drug Absorption After Oral AdministrationClinical Pharmacokinetics, 1999
- Effects of Food on Clinical PharmacokineticsClinical Pharmacokinetics, 1999
- AD-5423 Dainippon Pharmaceutical Co Ltd.1998